Welcome
Support Centre
09 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Advance care planning in advanced cancer - can it be achieved? A patient preference trial of a care planning discussion
ISRCTN ISRCTN27270911
ClinicalTrials.gov identifier
Public title Advance care planning in advanced cancer - can it be achieved? A patient preference trial of a care planning discussion
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis 1. What is the acceptability and feasibility of a patient preference randomised controlled trial of an intervention to facilitate planning for end-of-life care?
2. Which outcomes are appropriate and measurable to assess the effectiveness of this intervention?
Lay summary Not provided at time of registration
Ethics approval Royal Free Hospital and Medical School Local Research Ethics Committee. Approved on 17.08.06, ref 06/Q501/93
Study design Randomised controlled patient preference trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer
Participants - inclusion criteria 1. Have completed a primary course of treatment and still have clinically detectable, progressive, active disease
2. Are considered by the referring health professional to be well enough to complete the advance care planning discussion
3. Are over 18 years of age
4. Are able to give informed consent
5. Do not have psychotic illness
6. Speak and understand English (able to complete the questionnaires/interview)
Participants - exclusion criteria 1. Have not completed a primary course of treatment and still have clinically detectable, progressive, active disease
2. Are not considered by the referring health professional to be well enough to complete the advance care planning discussion
3. Are under 18 years of age
4. Are unable to give informed consent
5. Have psychotic illness
6. Do not speak and understand English (able to complete the questionnaires/interview)
Anticipated start date 15/01/2007
Anticipated end date 07/07/2008
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 100
Interventions The intervention will consist of a one-to-one discussion with a trained mediator using a checklist of topic domains. Discussions will take place usually in participants' homes and last no more than one hour. Participants will be offered up to two further sessions with the mediator, to take place at a time of their choice. Discussions will be audio-taped and transcribed to examine the range and development of topics covered, how these change with time, and to ensure that the advisor has covered each domain as appropriate.
Primary outcome measure(s) Change in scores on visual analogue scales measuring ability to discuss end-of-life planning with primary and secondary care professionals and close persons/members of the family
Secondary outcome measure(s) 1. Completion of an advance directive
2. Psychological status
3. Satisfaction with care
Sources of funding Dimbleby Cancer Care (United Kingdom)
Trial website
Publications 1. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21352613
Contact name Dr  Louise  Jones
  Address Marie Curie Palliative Care Research Unit
Royal Free and University College Medical School
Hampstead Campus
Rowland Hill Street
  City/town London
  Zip/Postcode NW3 2PF
  Country United Kingdom
  Email l.jones@medsch.ucl.ac.uk
Sponsor University College London (UK)
  Address Gower Street
  City/town London
  Zip/Postcode WC1E 6BT
  Country United Kingdom
  Email o.avwenagha@medsch.ucl.ac.uk
  Sponsor website: http://www.ucl.ac.uk/
Date applied 08/01/2007
Last edited 05/01/2012
Date ISRCTN assigned 16/02/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central